ing. B.N. Hoogeboom

No picture available
E-mail:
b.n.hoogeboom umcg.nl

Research

Publications
  1. Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?

    Koutsoumpli, G., Ip, P. P., Schepel, I., Hoogeboom, B. N., Boerma, A. & Daemen, T., 3-Oct-2019, In : Therapeutic Advances in Vaccines and Immunotherapy. 7, p. 1-13 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

    Draghiciu, O., Boerma, A., Hoogeboom, B. N., Nijman, H. W. & Daemen, T., 2015, In : OncoImmunology. 4, 10, 9 p., 1029699.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

    van de Wall, S., Walczak, M., van Rooij, N., Hoogeboom, B-N., Meijerhof, T., Nijman, H. W. & Daemen, T., 24-Mar-2015, In : Vaccines. 3, 2, p. 221-238 18 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Potentiation of a P53-SLP vaccine by cyclophosphamide in ovarian cancer, A single ARM phase II study

    Vermeij, R., Leffers, N., Hoogeboom, B-N., Hamming, I. E., Wolf, R., Reyners, A. K. L., Molmans, B. H. W., Hollema, H., Bart, J., Drijfhout, J. W., Oostendorp, J., Van Der Zee, A. G. J., Melief, C. J., Van Der Burg, S. H., Daemen, T. & Nijman, H. W., 1-Oct-2011, In : International Journal of Gynecological Cancer. 21, 12, p. 67 1 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (15) »

ID: 218792